Anthem Biosciences consolidated net profit declines 11.67% in the June 2026 quarter
(21 Jul 2026)

Back
Net profit of Anthem Biosciences declined 11.67% to Rs 119.94 crore in the quarter ended June 2026 as against Rs 135.79 crore during the previous quarter ended June 2025. Sales declined 22.58% to Rs 418.22 crore in the quarter ended June 2026 as against Rs 540.21 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales418.22540.21 -23
OPM %36.0035.45 -
PBDT174.57212.69 -18
PBT144.58186.25 -22
NP119.94135.79 -12
BSE Delayed data sourced at 5 mins : www.bseindia.com | NSE Delayed data sourced at 15 mins : www.nseindia.com

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew